02/14/2025 8:44 AM | MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form SCHEDULE 13G | |
02/12/2025 8:30 AM | FMR LLC (Filed by) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025 8:55 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Reich Kristian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 3:30 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:03 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:05 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/08/2024 5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by) MoonLake Immunotherapeutics (Subject) MoonLake Immunotherapeutics (Subject)
| Form SC 13D/A | |
10/08/2024 5:50 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) LAMPERT MARK N (Reporting) MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 6:30 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:02 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:04 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for MLTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MoonLake Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
06/10/2024 4:06 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting) BIOTECHNOLOGY VALUE FUND L P (Reporting) Biotechnology Value Trading Fund OS LP (Reporting) BVF GP HOLDINGS LLC (Reporting) BVF I GP LLC (Reporting) BVF II GP LLC (Reporting) BVF INC/IL (Reporting) BVF PARTNERS L P/IL (Reporting) BVF Partners OS Ltd. (Reporting) LAMPERT MARK N (Reporting) MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/10/2024 3:40 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/06/2024 6:30 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:01 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 7:02 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024 6:57 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-K/A | |
04/24/2024 3:30 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form DEF 14A | |
04/24/2024 3:31 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form DEFA14A | |
04/24/2024 3:33 PM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form ARS | |
03/11/2024 7:01 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 6:53 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Reich Kristian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:56 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Santos da Silva Jorge (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 7:03 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:05 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/26/2024 8:00 AM | MoonLake Immunotherapeutics (Filer) MoonLake Immunotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/22/2024 5:32 PM | MoonLake Immunotherapeutics (Issuer) MoonLake Immunotherapeutics (Issuer) Reich Kristian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |